Postmenopausal: Clinical Trials

1 trial for Postmenopausal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Postmenopausal: new trials by email Literature Review of Postmenopausal trials Research Report on Postmenopausal

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients
Ribociclib, Trastuzumab, Letrozole - HER2-positive Breast Cancer, Postmenopausal
Phase 1 / Phase 2UnknownYonsei University952019-06-102022-05-10

Narrower conditions

Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Letrozole (1)  ·  Trastuzumab (1)  ·  ribociclib (1)

Sponsors

Yonsei University (1)

Countries

South Korea (1)